Fibrosis pulmonar idiopática (FPI)

 

Effects of nintedanib in patients with idiopathic pulmonary fibrosis and varying severities of cough

Wuyts WA et al.

 

Acceder

Associations between circulating microRNAs and clinical outcomes in patients with IPF: data from the IPF-PRO Registry

Luckhardt TR et al.
 

Acceder

Associations between circulating matrix metalloproteinases and their inhibitors and mortality in patients with IPF: data from the IPF-PRO Registry

Todd JL. et al.
 

Acceder

 

 

Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

de Andrade J et al.

 

Acceder

Exploring relationships between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

de Andrade JA et al.
 

Acceder

Characteristics of patients with idiopathic pulmonary fibrosis admitted to hospital: data from the IPF-PRO Registry

Strek ME et al.

 

Acceder

 

 

Post-hospitalization mortality in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Kim HJ et al.

 

Acceder

Disparities in lung transplantation among patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Swaminathan A et al.
 

Acceder

Impact of initiating nintedanib earlier versus later in patients newly diagnosed with idiopathic pulmonary fibrosis

Singer D et al.
 

Acceder

¿Te ha resultado útil esta información?